The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
Read more
Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.
Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Read More
Read more
Could it be COVID? Here are the symptoms to watch out for in 2024
COVID symptoms can be mild, severe, or nonexistent, according to the CDC—and can appear as late as two weeks after ...
Read more
GSK, Pfizer RSV shots must warn about rare paralysis risk
An analysis found nine excess cases of Guillain-Barré for every million doses given. Read More
Read more
Mark Cuban’s Cost Plus Drugs will begin manufacturing its own medications this week
The “Shark Tank” investor and Cost Plus Drugs cofounder Dr. Alex Oshmyansky participated in a White House health care roundtable. ...
Read more
Mark Cuban says CEOs don’t understand their health care costs. Here’s what the Cost Plus Drugs cofounder’s mistakes have taught him
“Even though health insurance costs are the second-largest line item after payroll, CEOs don’t really understand it or know anything ...
Read more
Mark Cuban once helped his college friend save almost $10,000 on prescriptions after a ‘horrific car accident’
Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just pills.” Read More
Read more
Bird flu could merge with seasonal flu to make mutated virus that could spread among humans, CDC warns
The 2024–25 flu shot doesn’t prevent H5N1 bird flu but could play a pivotal role in preventing a pandemic. Read ...
Read more
Public health experts are warning of a ‘quad-demic’ this winter. Here’s where flu, COVID, RSV, and norovirus are spreading
Taking precautions to protect yourself from the quartet of infectious diseases can lessen your odds of bringing an illness into ...
Read more
RFK Plans to Take on Big Pharma. It’s Easier Said Than Done
But the administration would likely face legal challenges if it proposed additional restrictions or an outright ban on pharma ads, ...
Read more
